| Literature DB >> 34389625 |
Tongcui Ma1,2, Heeju Ryu3, Matthew McGregor1,2, Benjamin Babcock4, Jason Neidleman1,2, Guorui Xie1,2, Ashley F George1,2, Julie Frouard1,2, Victoria Murray5, Gurjot Gill5, Eliver Ghosn4,6, Evan W Newell3, Sulggi A Lee7, Nadia R Roan8,2.
Abstract
CD8+ T cells can potentiate long-lived immunity against COVID-19. We screened longitudinally-sampled convalescent human donors against SARS-CoV-2 tetramers and identified a participant with an immunodominant response against residues 322 to 311 of nucleocapsid (Nuc322-331), a peptide conserved in all variants of concern reported to date. We conducted 38-parameter cytometry by time of flight on tetramer-identified Nuc322-331-specific CD8+ T cells and on CD4+ and CD8+ T cells recognizing the entire nucleocapsid and spike proteins, and took 32 serological measurements. We discovered a coordination of the Nuc322-331-specific CD8+ T response with both the CD4+ T cell and Ab pillars of adaptive immunity. Over the approximately six month period of convalescence monitored, we observed a slow and progressive decrease in the activation state and polyfunctionality of Nuc322-331-specific CD8+ T cells, accompanied by an increase in their lymph node-homing and homeostatic proliferation potential. These results suggest that following a typical case of mild COVID-19, SARS-CoV-2-specific CD8+ T cells not only persist but continuously differentiate in a coordinated fashion well into convalescence into a state characteristic of long-lived, self-renewing memory.Entities:
Mesh:
Year: 2021 PMID: 34389625 PMCID: PMC8763019 DOI: 10.4049/jimmunol.2100465
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422